Latest News

  • New technique allows technicolour imaging of degenerative joint disease

    Medical imaging is no longer in Kansas, Toto, as a team led by Penn State researchers brings traditional black and white diagnostic images of X-rays and traditional CT scans into technicolour. The researchers developed novel contrast agents that target two proteins implicated in osteoarthritis, a degenerative joint disease commonly characterised as wear-and-tear arthritis. By marking [...]

  • Education, occupation, and wealth affect the risk of cognitive impairment

    Socioeconomic factors such as education, occupation, and wealth influence the likelihood of developing cognitive impairment or dementia in later life and whether a person is likely to recover, finds a new study led by UCL researchers. The research followed 8,442 adults aged 50 and above in England over 10 years from 2008/09 to 2018/19, to [...]

  • My family didn’t have a choice when it came to dementia care – technology can ensure others do

    Sunday afternoons spent with my Grandad were a staple of my childhood. For as long as I can remember, once a month, we would set up in our living room, equipped with a pack of cards, a cuppa and the score from yesterday’s Crystal Palace game and sit for hours playing Newmarket. Weekends had always [...]

  • Childhood neglect associated with stroke, COPD, cognitive impairment and depression

    New research from the University of Toronto found that childhood neglect, even in the absence of childhood sexual abuse and physical abuse, is linked with a wide range of mental and physical health problems in adulthood. The researchers found significant associations between childhood neglect and numerous health problems in adults when controlling for age, sex [...]

  • Taking five or more medications can negatively impact Alzheimer’s disease

    Polypharmacy, commonly defined as taking five or more medications daily, is a significant health care concern impacting over 30 per cent of older adults. It is associated with poor health outcomes like falls, medication interactions, hospitalisations and even death. Older adults are at an increased risk of experiencing polypharmacy if they have multiple chronic conditions. [...]

  • ‘Black box’ of stem cell transplants opened in world-first blood study

    For the first time, scientists have tracked what happens to stem cells decades after a transplant, lifting the lid on the procedure that has been a medical mystery for over 50 years. A growing body of evidence suggests that stem cell transplants may be affected by ageing process, impacting their ability to renew. Researchers from [...]

  • Rapid horizontal eye movement can improve stability in people with Parkinson’s

    Rapid side-to-side eye movements can help stabilise posture, avoid falls and maintain balance for people with Parkinson’s disease, just as they can for healthy people. This seemingly counterintuitive conclusion was reached by researchers at São Paulo State University (UNESP) in Brazil and the University of Lille in France in a study supported by FAPESP. An [...]

  • Dangerous gap in knowledge about pancreatic cancer among adults under age 50

    While pancreatic cancer rates are rising in people under age 50, a new survey conducted by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) shows most people continue to believe that pancreatic disease affects only the elderly – and that there [...]

  • Women entering menopause later in life at greater risk for asthma

    Many studies suggest that an earlier age at menopause is more detrimental to a woman’s health, leading to an increased risk for adverse health conditions such as heart disease, diabetes, osteoporosis, and depression, among others. However, a new study is linking a later age at natural menopause with a greater risk for asthma. Asthma is a common, [...]

  • Investigating new treatments for blindness-causing diseases

    Researchers have been collaborating to develop compounds to treat dry age-related macular degeneration (AMD) and Stargardt disease - both blindness-causing diseases. The team’s work has led to the discovery of an advanced preclinical candidate. Now, Cioffi and Petruhkin have received a $6.4 million grant over five years from the National Institutes of Heath’s National Eye Institute [...]